Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma

Several studies have indicated that radioimmunotherapy is an effective and clinically relevant complementary therapeutic approach for patients with B-cell non-Hodgkin’s lymphoma (NHL) and may convert partial to complete response when given as consolidation after induction chemotherapy. Yttrium-90((9...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Emmanouilides, Christos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2009
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004670/
https://ncbi.nlm.nih.gov/pubmed/21188131
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller